KZR
Kezar Life Sciences Inc
0.175$
+6.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -177.5% | – | – | – | – | -100.0% | – | – | – | – | – | |
| – | +11.6% | +0.7% | -7.1% | +0.4% | -0.4% | -0.4% | -3.1% | – | – | -22.5% | – | – | |
| – | – | -104.2% | – | – | – | – | -148.2% | – | – | – | – | – | |
| – | +13.0% | -4.6% | -24.2% | -5.1% | -0.3% | -1.3% | -24.0% | -21.3% | -27.9% | -26.5% | -69.6% | – | |
| – | +51.9% | -37.6% | +19.3% | -14.3% | +1.8% | -2.8% | -1.7% | -7.9% | -4.3% | -32.3% | +60.3% | – | |
| – | +20.4% | -12.8% | -16.6% | -0.3% | -6.1% | -1.8% | -18.2% | -17.2% | -19.8% | -30.4% | -9.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.9% | +0.8% | +0.3% | +0.2% | +0.5% | -3.5% | -10.8% | -13.0% | +78.1% | -66.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -109.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.